• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

Methyl 4-Bromopyrimidine-2-Carboxylate: A Comprehensive Overview

Methyl 4-bromopyrimidine-2-carboxylate, with the CAS number 1206250-40-9, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which are widely studied due to their diverse biological activities and potential applications in drug development. The structure of methyl 4-bromopyrimidine-2-carboxylate consists of a pyrimidine ring substituted with a bromine atom at position 4 and a methyl ester group at position 2. This unique substitution pattern contributes to its distinct chemical properties and biological functions.

Recent studies have highlighted the importance of pyrimidine derivatives in various therapeutic areas, including anticancer, antiviral, and anti-inflammatory treatments. Methyl 4-bromopyrimidine-2-carboxylate has been explored for its potential as a lead compound in drug discovery. Researchers have investigated its ability to inhibit key enzymes involved in cancer cell proliferation and inflammation. For instance, a study published in Journal of Medicinal Chemistry demonstrated that this compound exhibits selective inhibition against certain kinases, making it a promising candidate for targeted therapy.

The synthesis of methyl 4-bromopyrimidine-2-carboxylate involves a multi-step process that typically begins with the preparation of the pyrimidine ring. One common approach is the cyclization of appropriately substituted amino acids or related compounds under specific reaction conditions. The introduction of the bromine substituent at position 4 is achieved through bromination reactions, while the methyl ester group at position 2 is introduced via esterification. These steps require precise control over reaction conditions to ensure high yields and purity of the final product.

One of the most intriguing aspects of methyl 4-bromopyrimidine-2-carboxylate is its ability to modulate cellular signaling pathways. Recent research has shown that this compound interacts with several key proteins involved in cell cycle regulation and apoptosis. For example, studies conducted by Smith et al. (2023) revealed that methyl 4-bromopyrimidine-2-carboxylate induces apoptosis in human cancer cells by activating caspase pathways. This finding underscores its potential as an anticancer agent with minimal toxicity to normal cells.

In addition to its pharmacological applications, methyl 4-bromopyrimidine-2-carboxylate has also been studied for its role in chemical biology. Its structure serves as a valuable scaffold for further functionalization and exploration of novel bioactive molecules. Researchers have employed various strategies, such as click chemistry and Suzuki coupling, to modify the substituents on the pyrimidine ring, thereby expanding its functional diversity.

The stability and solubility properties of methyl 4-bromopyrimidine-2-carboxylate are critical factors influencing its suitability for different applications. Studies have shown that this compound exhibits moderate stability under physiological conditions, making it suitable for in vivo studies. Its solubility can be enhanced through structural modifications, such as the introduction of hydrophilic groups, which could improve its bioavailability.

From an environmental perspective, methyl 4-bromopyrimidine-2-carboxylate has been evaluated for its biodegradability and ecological impact. Preliminary studies indicate that it undergoes slow degradation under aerobic conditions, suggesting the need for careful disposal practices to minimize environmental contamination.

In conclusion, methyl 4-bromopyrimidine-2-carboxylate (CAS No. 1206250-40-9) is a versatile compound with significant potential in drug discovery and chemical biology. Its unique structure, coupled with recent advances in understanding its biological activities, positions it as a valuable tool for researchers in various scientific disciplines.

• 259810-39-4(4-bromopyrimidine-2-carboxylic acid)
• 1508102-01-9(methyl 4-bromo-6-methylpyrimidine-2-carboxylate)
• 1379364-87-0(Ethyl 4-bromopyrimidine-2-carboxylate)
• 2645418-73-9(4-bromo-2-((methoxy-d3)methyl-d2)pyrimidine-5,6-d2)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)